Gregory L. Barnett
Treasurer presso BioSphere Medical, Inc.
Profilo
Mr. Gregory L.
Barnett is Treasurer at BioSphere Medical, Inc. and Chief Accounting Officer at Merit Medical Systems, Inc.
He received his undergraduate degree from the University of Utah.
Posizioni attive di Gregory L. Barnett
Società | Posizione | Inizio |
---|---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Treasurer | 14/09/2010 |
Precedenti posizioni note di Gregory L. Barnett
Società | Posizione | Fine |
---|---|---|
MERIT MEDICAL SYSTEMS, INC. | Comptroller/Controller/Auditor | 04/11/2015 |
Formazione di Gregory L. Barnett
University of Utah | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERIT MEDICAL SYSTEMS, INC. | Health Technology |
Aziende private | 1 |
---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
- Borsa valori
- Insiders
- Gregory L. Barnett